{
    "Trade/Device Name(s)": [
        "Total Protein Urine/CSF Gen. 3",
        "C.f.a.s. TPUC 200"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K071239",
    "Predicate Device Reference 510(k) Number(s)": [
        "K913615"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGQ",
        "JIX"
    ],
    "Summary Letter Date": "August 16, 2007",
    "Summary Letter Received Date": "August 17, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1635"
    ],
    "Regulation Name(s)": [
        "Total Protein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total protein"
    ],
    "Specimen Type(s)": [
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "COBAS INTEGRA family of analyzers",
        "Roche/Hitachi family of analyzers",
        "cobas c501 platform"
    ],
    "Method(s)/Technology(ies)": [
        "Endpoint assay",
        "Turbidimetric"
    ],
    "Methodologies": [
        "Quantitative determination"
    ],
    "Submission Type(s)": [
        "Test System",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics Total Protein Urine/CSF Gen. 3 and C.f.a.s. TPUC 200 calibrator for quantitative protein testing on COBAS INTEGRA and Roche/Hitachi analyzers",
    "Indications for Use Summary": "In vitro test for quantitative determination of total protein in urine and cerebrospinal fluid on COBAS INTEGRA systems; used in diagnosis and treatment of renal, heart, thyroid, liver, kidney, bone marrow, metabolic, nutritional and CNS disorders.",
    "fda_folder": "Clinical Chemistry"
}